Symptom-centric view
Peripheral swelling
Substances reporting Peripheral swelling disproportionately — ranked by ROR.
showing 9 of 9
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
nicotinamide Niacinamide | 17.9 [15.8–20.3] | 279 | longevity | new |
| 5.1 [5.0–5.3] | 5,519 | algemeen | new | |
| 4.3 [4.2–4.4] | 7,290 | algemeen | new | |
| 16.3 [15.4–17.2] | 1,466 | algemeen | new | |
| 4.3 [4.2–4.4] | 7,300 | algemeen | new | |
| 2.8 [2.8–2.9] | 12,889 | algemeen | new | |
| 2.1 [1.8–2.4] | 170 | algemeen | new | |
| 9.2 [9.0–9.4] | 8,171 | algemeen | new | |
| 3.7 [3.5–3.9] | 1,224 | algemeen | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).